TIDMGSK

RNS Number : 0220C

GlaxoSmithKline PLC

12 June 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  =========================================== 
 b)   Position/status          Chief Executive Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   7 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   7 (matching shares) 
                                              ----------------------- 
===  ========================  =========================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 14 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  ============================================ 
 b)   Position/status          President, Global Vaccines 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  =========================================== 
 b)   Position/status          SVP, Global Ethics and Compliance 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  =========================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Ms S Jackson 
===  ========================  ============================================ 
 b)   Position/status          SVP, Global Communications and CEO Office 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                     Mr D Jackson 
===  ========================  =============================================== 
 b)   Position/status          PCA of Ms S Jackson (SVP, Global Communications 
                                and CEO Office) 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  =============================================== 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  =============================================== 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  =============================================== 
 e)   Date of the transaction  2019-06-11 
===  ========================  =============================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr D S Redfern 
===  ========================  ============================================ 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   7 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   7 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 14 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  ============================================ 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mr P C Thomson 
===  ========================  ============================================ 
 b)   Position/status          President, Global Affairs 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ====================================================================== 
 a)   Name                     Mrs V A Whyte 
===  ========================  ============================================ 
 b)   Position/status          Company Secretary 
===  ========================  ============================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the             Acquisition of Ordinary Shares under the 
       transaction               Company's Share Reward Plan. 
===  ========================  ============================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                  GBP15.8480   8 (partnership shares) 
                                              ----------------------- 
                                  GBP15.8480   8 (matching shares) 
                                              ----------------------- 
===  ========================  ============================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
 
                                 16 Ordinary Shares 
                                 GBP15.8480 
===  ========================  ============================================ 
 e)   Date of the transaction  2019-06-11 
===  ========================  ============================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ============================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQLLFFKQFBBBB

(END) Dow Jones Newswires

June 12, 2019 12:10 ET (16:10 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.